Arcus Biosciences Inc (RCUS) financials · rev $247.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Arcus Biosciences Inc (RCUS) rev $247.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $247.0M | $258.0M |
| Operating Income | -$386.0M | -$330.0M |
| Net Income | -$353.0M | -$283.0M |
| EPS (Diluted) | -$3.29 | -$3.14 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.14B | $1.15B |
| Current Assets | $1.01B | $1.02B |
| Cash & Equivalents | $222.0M | $150.0M |
| PP&E | $40.0M | $47.0M |
| Total Liabilities | $508.0M | $665.0M |
| Current Liabilities | $231.0M | $226.0M |
| Long-term Debt | $99.0M | $48.0M |
| Total Debt | $99.0M† | $48.0M† |
| Shareholders' Equity | $631.0M | $485.0M |
| Retained Earnings | -$1.49B | -$1.13B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$482.0M | -$170.0M |
| CapEx | $2.00M | $6.00M |
| Investing Cash Flow | $66.0M | -$84.0M |
| Financing Cash Flow | $488.0M | $277.0M |
| Net Change in Cash | $72.0M | $23.0M |
| Free Cash Flow | -$484.0M | -$176.0M |
FAQ
What is RCUS P/E and revenue?
Arcus Biosciences Inc (RCUS) rev $247.0M.
What is RCUS revenue?
Arcus Biosciences Inc last cached revenue is $247.0M (FY2025).
Is RCUS profitable?
Arcus Biosciences Inc last cached net income is -$353.0M (FY2025).
What are RCUS total assets?
Arcus Biosciences Inc last cached total assets are $1.14B (FY2025).
What is RCUS free cash flow?
Arcus Biosciences Inc last cached free cash flow is -$484.0M (FY2025).
Not investment advice. Cached statements, not a live tape.